2020 INTERNATIONAL SYNGAP1 SCIENTIFIC CONFERENCE

VIRTUAL HUB PAGE

SYNGAP1 - Awareness, Advocacy, Education & Research

2020 VIRTUAL INTERNATIONAL SYNGAP1 SCIENTIFIC CONFERENCE


Brought to you by
November 17 - 19, 2020

*Virtual - Live Stream Interactive Conference

Welcome to BTG's
2020 Virtual International SYNGAP1 Scientific Conference Hub Page!

LINKS TO LIVE STREAM PAGES
DAY 1

Young Neuroscience Investigator Career Development Workshop

Tuesday, November 17, 2020

CLICK HERE FOR LIVE STREAM
DAY 2

MAIN CONFERENCE - Full Day

Wednesday, November 18, 2020

CLICK HERE FOR LIVE STREAM
DAY 3

MAIN CONFERENCE - Half Day


Thursday, November 19, 2020

CLICK HERE FOR LIVE STREAM
Ready to Launch!
NEURO - GUT SMURFCAKE TRANSIT STUDY
JOIN US - NOVEMBER 19th
TIME: 11:30 am - 12:15 pm, EST, U.S. & Canada

REGISTER HERE FOR THE KICK OFF MEETING!
YOU WILL NOT WANT TO MISS THIS IMPORTANT SYNGAP1 COMMUNITY MEETING!

Externally Led - Patient Focused Drug Development Meeting
SYNGAP1: Patient & Caregiver Voices

Thursday, November 19, 2020


12:30 pm - 5:00 pm, EST, U.S. & Canada

Check it out HERE!      This is a Free Event!
2020 INTERNATIONAL SYNGAP1 CONFERENCE

SPONSORS

International SYNGAP1 Scientific Conference -
General Information

Bridge the Gap’s International SYNGAP1 Conference provides a cutting-edge, scientific and educational
forum focused on bringing together a diverse group of SYNAP1 Community stakeholders.  SYNGAP1 Community stakeholders include - research scientists, clinical specialists, SYNGAP1 Families, industry, academic, government and community leaders.  

In addition, the conferences provide opportunities to bring  together scientists and clinicians actively involved in SYNGAP1 Research with trainees, young investigators, and underrepresented minorities, as well as, experts in the development of targeted therapies related to neurodevelopmental disorders.  Our goal is to increase participation of trainees, young investigators and underrepresented minorities in neurodevelopmental disorder research and to encourage the development of targeted therapies to treat SYNGAP1 and related neurodevelopmental disorders.

The conferences are designed to maximize scientific resources, encourage opportunities for collaboration and provide a forum that is inclusive for SYNGAP1 families and caregivers.  Each conference features a broad range of session topics related to SYNGAP1 mutations, related neurodevelopmental disorders, published and unpublished research data and patient-centric study design. Time is allotted during each presentation for SYNGAP1 experts to lead discussions on current and future avenues of research.
Questions? Contact Us